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Abstract		
Oxidative	phosphorylation	(OXPHOS)	is	the	metabolic	pathway	in	mitochondria	
that	produces	the	large	majority	of	ATP	used	by	the	cell.	Superoxide,	a	reactive	oxygen	
species	(ROS),	is	generated	during	OXPHOS	when	electrons	are	prematurely	transferred	
to	 oxygen.	 Although	 ROS	 are	 necessary	 for	 certain	 cell	 signaling	 pathways,	 they	 are	
generally	 thought	 to	 be	 damaging	 to	 the	 cell.	 Cells	 can	 protect	 themselves	 against	
oxidative	damage	using	antioxidant	enzymes	that	break	down	superoxide	and	other	ROS.	
Antioxidants	 are	 currently	 used	 as	 therapeutics	 for	 a	 number	 of	 diseases,	 but	 so	 far,	
mitochondria	targeted	antioxidants	have	not	been	well	characterized	for	this	purpose.	
Manganese	 superoxide	 dismutase	 (SOD2)	 is	 an	 antioxidant	 enzyme	 found	 in	
mitochondria	that	converts	superoxide	into	hydrogen	peroxide.	This	project	focuses	on	
mice	 that	 overexpress	 SOD2.	 Microarray	 analysis	 of	 gene	 expression	 in	 these	 mice	
showed	potentially	defective	OXPHOS	gene	expression.	Preliminary	studies	confirmed	
reductions	 of	 complexes	 II	 and	 III	 in	 the	 SOD2	 samples	 by	 sodium	 dodecyl	 sulfate	
polyacrylamide	gel	electrophoresis	(SDS-PAGE),	and	a	reduction	of	complex	II	assembly	
in	the	SOD2	liver	samples	by	blue	native	PAGE.	Current	studies	have	shown	that	SOD2	
mice	have	reduced	assembly	of	complex	II	and	V	by	BN-PAGE,	but	unchanged	assembly	
of	complexes	I	and	III	by	the	same	method.	To	follow	up	on	these	results,	activity	assays	
indicate	a	decrease	in	complex	II	activity	and	a	potential	increase	in	complex	I	activity.	
Aconitase	showed	an	increase	in	activity	in	SOD2	samples	as	well.	Taken	together,	this	
implicates	that	overexpression	of	SOD2	causes	defects	in	OXPHOS.		
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Introduction	
Relevance	
	 Free	 radicals	 are	 generated	 in	 mitochondria	 as	 a	 byproduct	 of	 oxidative	
phosphorylation	 and	 can	 be	 damaging	 to	 the	 cell.	 Oxidative	 damage	 can	 have	major	
health	 consequences,	 and	 can	 contribute	 to	 various	 diseases	 such	 as	 cancer,	 aging,	
diabetes,	and	Alzheimer’s	disease.3-6	The	health	benefits	of	antioxidants,	which	eliminate	
reactive	oxygen	species,	are	well	recognized	but	are	mechanistically	not	well	understood.	
This	 project	 focuses	 on	 investigating	 the	 physiological	 consequences	 of	 targeted	
antioxidants.	A	preliminary	microarray	was	conducted	using	RNA	isolated	from	livers	of	
mice	 that	 overexpress	 the	 mitochondrial	 antioxidant	 enzyme	 superoxide	 dismutase.	
Although	it	was	expected	that	increased	detoxification	of	superoxide	would	be	beneficial	
to	 oxidative	 phosphorylation,	 gene	 expression	 analysis	 actually	 showed	 potential	
defects.	Since	reactive	oxygen	species	are	known	to	participate	as	signaling	molecules	in	
a	number	of	pathways,	it	is	possible	that	high	levels	of	antioxidants	could	be	detrimental.	
This	 study	 has	 important	 implications	 for	 antioxidant	 therapeutics,	 specifically	when	
used	to	treat	diseases	characterized	by	impaired	liver	function.	
Mitochondria	and	Oxidative	Phosphorylation	
	Mitochondria	 are	 dual-membrane	 organelles	 found	 in	 eukaryotes	 that	 are	
responsible	 for	oxygen	consumption	and	ATP	production.7	Oxidative	phosphorylation	
(OXPHOS)	is	the	metabolic	pathway	in	mitochondria	that	generates	a	large	majority	of	
cellular	ATP.	During	OXPHOS,	a	series	of	oxidation-reduction	reactions	transfer	electrons	
from	NADH	 and	 FADH2	 through	 four	 electron	 transport	 complexes	 and	 ultimately	 to	
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molecular	 oxygen	 to	 form	
water.8	 These	 four	 multi-
subunit	 complexes	are	NADH	
dehydrogenase	(complex	I;	45	
proteins),	 succinate	
dehydrogenase	 (complex	 II;	
4	proteins),	 ubiquinone-
cytochrome	 c	 oxidoreductase	
(complex	III;	11	proteins),	and	
cytochrome	 c	 oxidase	
(complex	 IV;	13	proteins).	As	
electrons	 flow,	 complexes	 I,	 III,	 and	 IV	 pump	protons	 across	 the	 inner	mitochondrial	
membrane	into	the	intermembrane	space	(Figure	1).	The	proton	gradient	generated	in	
the	 intermembrane	 space	 provides	 chemiosmotic	 energy	 to	 drive	 ATP	 production	 as	
protons	 move	 back	 across	 the	 membrane	 through	 ATP	 synthase	 (complex	 V;	 17	
proteins).	 All	 OXPHOS	 complexes,	 with	 the	 exception	 of	 complex	 II,	 contain	 critical	
proteins	that	are	encoded	in	mitochondrial	DNA.		
Mitochondrial	DNA	
	 	Mitochondria	 are	 specialized	 organelles	 that	 have	 their	 own	 genome.		
Mitochondrial	 DNA	 (mtDNA)	 is	 maternally	 inherited	 and	 is	 a	 closed	 circular	 DNA	
molecule	composed	of	~17,000	base	pairs	(Figure	2).9	Each	eukaryotic	cell	contains	100-
10,000	copies	of	mtDNA.10	mtDNA	encodes	two	ribosomal	RNAs,	22	transfer	RNAs,	and	
	
Figure	 1.	 Oxidative	 phosphorylation	 in	
mitochondria.	The	transfer	of	electrons	from	NADH	
and	FADH2	through	complexes	I	through	IV	reduces	
oxygen	to	form	water.	Alternatively,	electrons	can	be	
prematurely	 transferred	 to	 oxygen	 to	 form	 the	
superoxide	 radical,	 O2·-.	 Proton-coupled	 electron	
transfer	generates	a	proton	gradient	that	drives	ATP	
synthesis.	 Figure	 modified	 from	 Ethan	 Sarnoski,	
unpublished.	
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13	proteins.9	All	13	proteins	encoded	
in	mtDNA	are	essential	components	of	
OXPHOS	 complexes.	 mtDNA	 is	
replicated,	transcribed,	and	translated	
within	the	organelle,	and	all	enzymes	
responsible	 for	 these	 processes	 are	
encoded	 in	 nuclear	 DNA.11	
Mitochondria	 and	 prokaryotes	 have	
many	 similarities,	 and	 it	 is	 thought	
that	 mitochondria	 evolved	 from	 an	
endosymbiotic	relationship	between	a	
bacterial	cell	and	its	host.11		
	OXPHOS	requires	90	proteins,	
13	 of	 which	 are	 encoded	 in	 mtDNA	
(Figure	 2)	 and	 77	 of	 which	 are	 encoded	 in	 nuclear	 DNA.	 Complex	 I	 contains	 7	
mitochondrial	 subunits	 (ND1,	 ND2,	 ND3,	 ND4L,	 ND4,	 ND5	 and	ND6)	 and	 38	 nuclear	
subunits.	In	complex	III,	1	of	the	11	proteins	(Cyt	b)	is	encoded	by	mtDNA.	Complex	IV	
contains	3	mitochondria-encoded	 subunits	 (COI,	COII,	 and	COIII)	 of	 13	 total,	 and	ATP	
synthase	has	2	of	its	17	proteins	(ATPase6	and	ATPase8)	encoded	in	mtDNA.	Proteins	that	
compose	 complex	 II	 are	 all	 encoded	 by	 nuclear	 DNA.	 Since	 functional	 oxidative	
phosphorylation	 requires	 assembly	 of	 protein	 subunits	 from	 both	 the	 nuclear	 and	
mitochondrial	 genomes,	 close	 coordination	 of	 gene	 expression	 must	 be	 maintained	
between	the	mitochondria	and	the	nucleus.	
	
Figure	 2.	 The	 mitochondrial	 genome.	
mtDNA	 encodes	 13	 proteins	 involved	 in	
OXPHOS.	 NADH	 dehydrogenase	 (ND),	
ubiquinone	 cytochrome	 c	 oxidoreductase	
(Cyt	b),	cytochrome	c	oxidase	(CO),	and	ATP	
synthase	 (ATPase)	 contain	 subunits	
encoded	within	 the	mitochondrial	genome.	
Figure	reproduced	with	permission.1	
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Reactive	Oxygen	Species	and	Antioxidants	
During	OXPHOS,	electrons	can	be	prematurely	transferred	to	oxygen	to	generate	
reactive	 oxygen	 species	 (ROS),	 specifically	 superoxide.	 Superoxide	 is	 a	 radical	 that	
contains	 a	 single	 unpaired	 electron	 and	 is	 converted	 in	 mitochondria	 to	 hydrogen	
peroxide	 (H2O2)	 by	 manganese	 superoxide	 dismutase	 (SOD2).	 Hydrogen	 peroxide	 is	
membrane	permeable	and	can	leave	the	mitochondria,	be	reduced	to	water	by	catalase,	
or	be	reduced	to	the	reactive	hydroxyl	radical	(OH•)	by	the	Fenton	reaction	with	iron	or	
copper.12	Although	small	 amounts	of	ROS	are	beneficial	 and	can	 function	as	 signaling	
molecules	that	contribute	to	pathways	such	as	growth,	metabolism,	differentiation,	and	
apoptosis,	they	are	generally	thought	to	be	damaging	at	high	concentrations.12	Oxidative	
damage	occurs	when	 the	amount	of	ROS	generated	exceeds	antioxidant	capacity.13	At	
high	levels,	ROS	can	damage	DNA,	RNA,	proteins,	and	lipids.14	ROS	can	induce	oxidation	
of	guanine,	resulting	in	the	aberrant	ability	to	base	pair	with	adenine.	ROS	can	oxidize	
and	inactivate	proteins	and	can	cause	lipid	peroxidation.	ROS	damage	to	mitochondrial	
DNA	 can	 impair	 OXPHOS,	 leading	 to	 more	 ROS	 production	 and	 a	 vicious	 cycle	 that	
provides	the	basis	for	the	free	radical	theory	of	aging.15	ROS	also	contribute	to	various	
degenerative	diseases	and	cancers.16	Cells	protect	themselves	against	free	radicals	using	
antioxidant	 enzymes	 such	 as	 thioredoxin,	 glutathione	 peroxidase,	 peroxiredoxin,	
superoxide	dismutases	,	and	catalase.17		
As	previously	mentioned,	SOD2	is	the	focus	of	this	project.	SOD2	is	an	antioxidant	enzyme	
that	 functions	as	a	 tetramer	 in	 the	mitochondrial	matrix	and	catalyzes	 the	reaction	of	
superoxide	into	hydrogen	peroxide	and	oxygen	using	manganese	as	a	cofactor	(equation	
1).	18	
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2O2•-	+	2H+	à	H2O2	+	O2	 	 	 (Equation	1)	
SOD2	reduces	Mn3+	to	Mn2+	and	oxidizes	superoxide	to	oxygen,	then	oxidizes	Mn2+	back	
to	 Mn3+	 to	 reduce	 superoxide	 to	 hydrogen	 peroxide.	 In	 this	 way,	 one	 molecule	 of	
superoxide	is	reduced	and	the	other	is	oxidized.18	
	Mice	 that	 overexpress	 SOD2	
have	 been	 developed	 and	
characterized20	and	are	used	in	
this	 project	 to	 identify	 genes	
responsive	 to	 mitochondrial	
ROS.	These	mice	have	 reduced	
superoxide	 in	 mitochondria	 in	
various	 tissues	 including	 the	
liver,	but	the	levels	of	hydrogen	peroxide	in	these	mice	have	not	been	determined	(Figure	
4).	Although	SOD2	is	not	the	only	enzyme	that	detoxifies	superoxide,	it	is	the	only	one	
that	does	so	 in	 the	mitochondrial	matrix,	where	 the	majority	of	cellular	superoxide	 is	
produced.	Copper/zinc	SOD	(SOD1)	is	a	homodimer	found	in	the	cytosol,	and	also	exists	
as	 a	 tetramer	 in	 the	 extracellular	 space	 (SOD3).19,	 21	 In	 the	 electron	 transport	 chain,	
complexes	I,	II,	and	III	contribute	the	most	to	the	production	of	superoxide.21			
A
B 	
Figure	4.	Experimental	mouse	model	system.	Mice	
overexpressing	 SOD2	 have	 reduced	 superoxide	
levels.	 (A)	 SOD2	 reduces	 superoxide	 to	 hydrogen	
peroxide	which	can	be	broken	down	into	water	and	
oxygen.	 (B)	 Mice	 with	 more	 SOD2	 have	 less	
superoxide.	
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Electron	Transport	Chain	and	OXPHOS	
NADH	dehydrogenase	(complex	I)	is	the	first	of	
the	 four	 complexes	 in	 the	 electron	 transport	 chain	
(Figure	 1).	 It	 is	 found	 in	 the	 mitochondrial	 inner	
membrane,	 and	 is	 responsible	 for	 oxidizing	
nicotinamide	adenine	dinucleotide	hydride	(NADH)	to	
NAD+	 and	 transferring	 two	 electrons	 to	 ubiquinone	
(Figure	 5).22	 Ubiquinone	 is	 a	 membrane-bound	 2-
electron	carrier	in	the	inner-mitochondrial	membrane.		
Ubiquinone,	when	reduced	to	ubiquinol	by	complex	I	or	
II,	can	transfer	electrons	to	complex	III.	 	If	ubiquinone	
only	accepts	one	electron,	it	becomes	a	radical	and	contributes	to	ROS	production.	This	
explains	why	complex	I	is	a	major	source	of	ROS	in	the	cell.	In	addition	to	transferring	
electrons,	complex	I	pumps	protons	into	the	intermembrane	space,	contributing	to	the	
proton	gradient	used	for	ATP	production.	Specifically,	four	protons	are	pumped	out	of	
the	mitochondrial	matrix	for	every	two	electrons	that	are	transferred	through	complex	
I.22	To	test	for	activity	of	complex	I,	NADH	will	be	used	as	a	substrate,	and	two	electrons	
will	 be	 transferred	 through	 complex	 I	 to	 ubiquinone,	 then	 ultimately	 to	 the	 artificial	
electron	acceptor	DCIP.	Reduction	of	DCIP	causes	a	color	change	from	blue	to	clear	that	
can	be	measured	in	a	spectrophotometer	at	600	nm.	Rotenone,	an	inhibitor	of	complex	I,	
inhibits	the	transfer	of	electrons	from	complex	I	to	ubiquinone.	
	
Figure	 5.	 NADH	
dehydrogenase	(complex	I).	
Transfer	of	electrons	occurs	
from	 NADH	 through	
complex	 I	 to	 ubiquinone,	
then	 to	 DCIP	 to	 form	
DCIPH2.	
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	 Succinate	 dehydrogenase	 (complex	 II)	 is	 the	
second	complex	in	the	electron	transport	chain	and	is	
responsible	 for	oxidizing	 succinate	 to	 fumarate.	The	
oxidation	of	succinate	is	coupled	with	the	reduction	of	
a	prosthetic	group	flavin	adenine	dinucleotide	(FAD)	
to	 the	 dihydrate	 form	 FADH2.23	 Electrons	 within	
complex	 II	 are	 ultimately	 transferred	 to	 ubiquinone	
(Figure	6).	Ubiquinol	is	again	used	to	carry	electrons	
to	complex	III.23	Complex	II	does	not	contribute	to	the	proton	gradient.	However,	with	
the	transfer	of	electrons	to	FAD,	complex	II	also	contributes	to	the	generation	of	ROS.	
Activity	of	complex	 II	will	be	measured	with	succinate	as	a	substrate	and	DCIP	as	 the	
terminal	electron	acceptor.		
	 Ubiquinone-cytochrome	c	oxidoreductase	 (Complex	 III)	 is	 the	 third	complex	 in	
the	 electron	 transport	 chain,	 and	 is	 responsible	 for	 reducing	 two	 molecules	 of	
cytochrome	c.	Cytochrome	c	is	a	one-electron	
carrier	 that	 is	 not	 membrane	 bound.24	 The	
reduction	 of	 cytochrome	 c	 is	 coupled	 to	
oxidation	 of	 ubiquinol	 generated	 by	
complexes	 I	 and	 II	 (Figure	 7).	 Since	
cytochrome	 c	 is	 a	 one-electron	 carrier,	
electrons	from	ubiquinol	must	be	transferred	
one	at	a	time.	The	transfer	of	a	single	electron	
generates	 a	 ubiquinone	 radical,	 which	 is	
	
Figure	 7.	 Ubiquinone-cytochrome	 c	
oxidoreductase	 (complex	 III).	
Electrons	 enter	 complex	 III	 as	
ubiquinol	 and	 are	 used	 to	 reduce	
cytochrome	 c.	 Transfer	 of	 electrons	
from	 ubiquinol	 to	 cytochrome	 c	
through	complex	III.	
	
Figure	 6.	 Succinate	
dehydrogenase	 (complex	 II).	
Electrons	 are	 transferred	
from	 succinate	 through	
complex	 II	 to	 reduce	
ubiquinone	to	ubiquinol.		
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subsequently	 reduced	during	 a	 second	 cycle	 of	 single	 electron	 transfer.	However,	 the	
ubiquinone	 radical	 can	 donate	 its	 single	 electron	 to	 oxygen	 to	 produce	 a	 superoxide	
radical,	 which	 explains	 how	 complex	 III	 contributes	 to	 the	 generation	 of	 ROS.25	
Therefore,	both	ubiquinol	molecules	from	complexes	I	and	II	enter	complex	III,	and	two	
cytochrome	 c	molecules	 are	 reduced.25	 Four	 hydrogens	 are	 again	 pumped	 out	 of	 the	
mitochondrial	 matrix	 from	 Complex	 III	 into	 the	
intermembrane	 space	 to	 contribute	 to	 the	 proton	
gradient.	 antimycin	 A,	 an	 inhibitor	 of	 complex	 III,	
prevents	ubiquinone	from	binding	to	cytochrome	b.26	
	 Cytochrome	 c	 oxidase	 (Complex	 IV)	 is	
responsible	 for	 oxidizing	 cytochrome	 c	 and	 reducing	
molecular	 oxygen	 to	 water	 (Figure	 8).	 It	 is	 the	 last	
complex	 in	 the	electron	 transport	 chain.	 Four	 reduced	
cytochrome	 c	 molecules	 are	 necessary	 to	 reduce	 one	
molecule	 of	 molecular	 oxygen	 to	 water.27	 Complex	 IV	
contributes	four	protons	to	the	proton	gradient.		
ATP	synthase	(Complex	V)	is	the	final	complex	in	
oxidative	 phosphorylation	 and	 is	 responsible	 for	 the	
generation	 of	 ATP.	 The	 build-up	 of	 protons	 in	 the	
intermembrane	space	provides	energy	in	the	form	of	the	
proton	 gradient.	 As	 protons	 flow	 back	 into	 the	matrix	
through	complex	V,	energy	from	the	proton	motive	force	
drives	synthesis	of	ATP.28	The	formation	of	ATP	occurs	
	
Figure	 8.	 Cytochrome	 c	
oxidase	 (complex	 IV).	
Electrons	from	cytochrome	
c	are	transferred	to	oxygen	
to	make	water.	
	
Figure	 9.	 ATP	 synthase	
(complex	 V).	 The	 proton	
gradient	 generated	 in	 the	
intermembrane	 space	
provides	 energy	 to	 form	
energy	from	ADP	and	Pi.	
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in	the	matrix	of	the	mitochondria	(Figure	9).	Adenosine	diphosphate	(ADP)	and	inorganic	
phosphate	(Pi)	are	both	necessary	cofactors	for	the	production	of	ATP.		
	 The	voltage	dependent	anion	channel	(VDAC)	is	found	on	the	outer	mitochondrial	
membrane	and	allows	for	metabolites	to	enter	and	leave	the	mitochondria	(Figure	10).2	
VDAC	allows	for	ADP	and	Pi	 to	enter	the	 intermembrane	space,	and	allows	for	ATP	to	
leave	the	intermembrane	space	into	the	cytosol	to	be	used	as	energy.	To	enter	the	matrix,	
ADP	 must	 go	 through	 the	 adenine	
nucleotide	translocator	(ANT),	Pi	must	go	
through	the	phosphate	transporter	(PT),	
and	produced	ATP	must	leave	the	matrix	
through	the	ANT.2	Overall,	 translocation	
of	ADP	and	ATP	between	the	matrix	and	
the	intermembrane	space	occurs	at	a	1:1	
ratio,	while	reducing	the	gradient	by	one	
proton.29	The	formation	of	one	ATP	from	
ADP	and	Pi	uses	four	protons.		
OXPHOS	and	the	Citric	Acid	Cycle	
In	addition	to	functioning	in	OXPHOS,	succinate	dehydrogenase	(complex	II)	also	
functions	 in	 the	 citric	 acid	 cycle.	 Since	 reductions	 in	 complex	 II	 were	 observed,	 it	 is	
possible	 that	 the	 citric	 acid	 cycle	 is	 also	affected	by	SOD2	expression.	Aconitase	 is	 an	
enzyme	that	converts	citrate	to	isocitrate	(Figure	11).	Aconitase	is	especially	sensitive	to	
ROS,	 since	 it	 contains	 a	 functionally	 important	 iron-sulfur	 center	 that	 is	 prone	 to	
	
Figure	 10.	 Representation	 of	 oxidative	
phosphorylation,	 ATP	 synthesis,	 and	
transporters.	 This	 figure	 shows	
complexes	I-V,	as	well	as	the	transporters	
voltage-dependent	anion	channel	(VDAC),	
adenine	 nucleotide	 translocator	 (ANT),	
monocarboxylate	 transporter	 (MT),	 and	
phosphate	 transporter	 (PT).	 Figure	
reproduced	with	permission.2		
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oxidation.30	 Following	 the	
aconitase	 reaction,	 isocitrate	
dehydrogenase	 converts	
isocitrate	into	a-ketogluterate	
and	 reduces	 NAD(P)+	 to	
NAD(P)H.	 	 Aconitase	 activity	
will	 be	 tested	 using	 a	 coupled	 reaction	 with	 isocitrate	 dehydrogenase,	 using	 the	
absorbance	at	340	nm	to	measure	the	generation	of	NADPH.		
Preliminary	Data	
	Microarrays	were	performed	on	RNA	 isolated	 from	wildtype	and	SOD2	mouse	
livers	 to	 determine	 superoxide-
dependent	 gene	 expression	
changes.	 Two	wild-type	 and	 two	
SOD2	 mice	 were	 analyzed.	
Although	 ~1,000	 hepatic	 genes	
were	 differentially	 expressed	 in	
SOD2	mice	compared	to	wild-type	
mice,	 a	 focus	 was	 placed	 on	
mitochondrial	 proteins	 for	 this	
project.	 Specifically,	 analysis	 of	
OXPHOS	gene	expression	showed	
a	 decrease	 in	 nuclear	 encoded	
OXPHOS	subunits	and	an	increase	
		 	
Figure	 12.	 Summary	 of	 preliminary	 microarray	
data.	 Gene	 expression	 analysis	 of	 SOD2	 mice	
showed	 a	 decrease	 in	 21	 nuclear-encoded	
OXPHOS	 subunits	 and	 an	 increase	 in	 5	 of	 the	
mitochondrial	 encoded	 genes	 as	 compared	 to	
wild-type	mice.	
	
Figure	 11.	 Reaction	 scheme	 of	 aconitase	 and	
isocitrate	 dehydrogenase.	 Aconitase	 converts	 citrate	
into	 isocitrate.	 Isocitrate	 dehydrogenase	 oxidizes	
isocitrate	 to	 a-ketogluterate	 and	 reduces	 NADP+	 to	
NADPH.	
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in	mtDNA-encoded	OXPHOS	subunits.	Of	the	nuclear-encoded	OXPHOS	subunits,	21	of	77	
(27.3%)	were	downregulated	 in	 the	SOD2	mice	 (Figure	5)	and	6	of	13	mitochondria-
encoded	subunits	(46.2%)	were	upregulated.	This	indicates	a	failure	in	mitochondria	to	
nucleus	 communication,	 because	 generally	 an	 increase	 in	 mitochondria-encoded	
subunits	 correlates	with	 an	 increase	 in	nuclear-encoded	 subunits	 to	 retain	 functional	
complexes.		
To	 verify	 microarray	 gene	 expression	 changes	 in	 OXPHOS	 complexes,	 sodium	
dodecyl	 sulfate	 polyacrylamide	 gel	 electrophoresis	 (SDS-PAGE)	 and	 blue	 native	
polyacrylamide	gel	electrophoresis	(BN-PAGE)	were	previously	performed	on	proteins	
isolated	from	livers	of	a	new	cohort	of	wild-type	and	SOD2	mice.	Complexes	II,	III,	and	V	
were	blotted	with	protein	specific	antibodies	to	observe	changes	in	protein	expression	
specific	to	each	complex.	4	wild-type	samples	and	5	SOD2	samples	were	run	on	the	SDS-
PAGE.	 The	 Western	 blot	 from	 the	 SDS-PAGE	 gel	 showed	 a	 significant	 reduction	 in	
individual	 protein	 levels	 from	 complexes	 II	 and	 III,	 but	 no	 significant	 change	 was	
observed	in	protein	levels	from	complex	V	(Figure	6A).	The	levels	of	expression	in	SOD2	
increased	 in	 the	 SOD2	 mutant	 mice	 compared	 to	 WT	 as	 expected.	 Although	 the	
expression	of	one	protein	of	the	complex	typically	indicates	a	reduction	in	assembly	of	
the	 entire	 complex,	 it	 is	 important	 to	 analyze	 complex	 assembly	 by	BN-PAGE.	 In	BN-
PAGE,	 detergents	 are	 selectively	 used	 to	 allow	 for	 migration	 of	 the	 intact	 complex	
through	the	gel.	Western	blots	are	done	using	antibodies	against	a	single	protein	in	the	
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complex,	and	the	resulting	band	intensity	is	attributed	to	the	intact	complex.	Preliminary	
BN-PAGE	was	 run	using	 3	wild-type	 samples	 and	3	 SOD2	 samples.	 The	Western	 blot	
showed	a	significant	decrease	in	complex	II	in	SOD2	mice	similar	to	the	SDS-PAGE	results,	
but	not	in	complex	III	(Figure	6C).		
Project	Goals	
The	focus	of	the	current	project	is	to	verify	changes	in	complex	II	by	BN-PAGE	in	
a	 different	 cohort	 of	 mice,	 as	 well	 as	 to	 investigate	 changes	 in	 other	 complexes.	 In	
addition,	 enzymatic	 activity	 of	 each	 complex	 will	 be	 tested.	 Even	 though	 OXPHOS	
A	 		B	 	
C				 	D	 	
Figure	 13.	 Previous	 preliminary	 data	 regarding	 OXPHOS	 gene	 expression.	 (A)	
Preliminary	SDS-PAGE	for	complexes	II,	III,	and	V.	SOD2	was	blotted	as	a	control	for	
overexpression.	(B)	Quantitation	of	gene	expression	changes	by	SDS-PAGE	shown	in	
A.	(C)	Preliminary	BN-PAGE	for	complexes	II	and	III	(D)	Quantitation	of	protein	bands	
from	BN-PAGE	 shown	 in	 C.	 Figure	 by	 Yichong	 Zhang,	 reproduced	with	 permission	
(personal	correspondence).	
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complexes	may	be	reduced	in	expression	levels,	an	increase	in	activity	could	potentially	
compensate	for	any	expression	deficits.		
Methods	
Antibodies	
	 The	 antibodies	 used	were	NDUFS3	 for	 complex	 I	 (1:500,	 Santa	 Cruz	 374282),	
SDHA	for	complex	II	(1:1,000	Santa	Cruz	377302),	UQCRC2	for	complex	IV	(1:500,	Santa	
Cruz	390161)	and	ATP5A	for	complex	V	(1:2,500	Santa	Cruz	136178).	For	all	primary	
antibodies,	donkey-anti-mouse	secondary	antibody	was	used	(Jackson	Labs).	
Mice	
	 The	SOD2	transgenic	mice	used	in	this	study	were	obtained	with	permission	from	
Arlan	 Richardson	 and	 have	 been	 characterized	 extensively.20	 All	 work	 with	 SOD2	
transgenic	 mice	 was	 carried	 out	 with	 Appalachian	 State	 IACUC	 and	 IBC	 approval	
(protocol	17-01).		These	mice	overexpress	superoxide	dismutase	and	are	maintained	as	
heterozygotes	with	one	copy	of	the	transgene.	Male	SOD2+/-	mice	were	bred	with	female	
nontransgenic	(wild-type)	mice.	Genotyping	to	verify	the	presence	of	the	transgene	was	
performed	by	PCR	analysis	of	DNA	isolated	from	toe	clippings	of	10	day	old	pups.	The	
mice	 were	 maintained	 in	 a	 temperature-controlled	 environment	 and	 fed	 chow.	 For	
analysis	of	liver	proteins,	male	and	female	mice	were	euthanized	at	10	weeks	of	age.	A	
total	of	8	SOD2	mice	and	8	wild-type	mice	were	used	in	this	study.	Livers	from	wild-type	
and	SOD2	mice	were	flash	frozen	in	liquid	nitrogen	and	ground	into	a	fine	powder	using	
a	cold,	stainless	steel	mortar	and	pestle.	
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Protein	Quantification	Assay	
Protein	 concentration	 was	 quantified	 using	 a	 bicinchoninic	 acid	 (BCA)	 assay	
(#23225,	Thermo	Fisher	Scientific).	Samples	were	diluted	1:20	 in	ACBT	buffer	 (1.5	M	
aminocaproic	acid,	75	mM	Bis-Tris,	pH	7.0)	prior	to	protein	determination.	In	a	96-well	
plate,	protein	standards	(5	µL	of	BSA	at	concentrations	ranging	from	0.01	to	0.05	mg/mL)	
were	used	to	create	a	standard	curve.	Separately,	2	µL,	3	µL,	4	µL,	and	5	µL	of	each	sample	
(buffer	compensated)	were	added	to	each	of	four	different	wells.	A	mixture	of	25:24:1	
parts	of	reagent	A,	reagent	B,	and	reagent	C	was	prepared	and	200	µL	was	added	to	each	
well.	The	plate	was	incubated	at	37	°C	for	30	minutes,	at	which	time	the	absorbance	was	
measured	 at	 562	nm.	 The	 absorbance	 of	 each	 sample	was	 compared	 to	 the	 standard	
curve	to	determine	protein	concentration.		
Blue-Native	PAGE	
Protein	Isolation	for	Blue-Native	PAGE	
	 To	isolate	protein	from	SOD2	and	wild-type	mice	for	blue-native	PAGE,	~20	mg	
liver	powder	was	homogenized	in	a	Teflon-glass	Potter-Elvehjem	homogenizer	in	250	µL	
ice	cold	MOPS	sucrose	buffer	(440	mM	sucrose,	20	mM	MOPS,	1	mM	EDTA)	for	6	strokes	
using	 a	 drill	 press.	 The	 homogenate	 was	 transferred	 to	 an	 Eppendorf	 tube	 and	
centrifuged	at	20,000	x	g	for	20	minutes	at	4	°C.	The	supernatant	was	removed,	and	40	µL	
ice	cold	ACBT	buffer	was	used	to	gently	resuspend	the	pellet.	To	each	sample,	3%	dodecyl	
maltoside	(DDM)	was	added	and	left	on	ice	for	10	minutes.	Samples	were	centrifuged	at	
20,000	x	g	for	20	minutes	at	4	°C,	and	the	pellet	was	discarded.		
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Blue-Native	PAGE	
BN-PAGE	was	performed	using	a	precast	4%-15%	Mini-Protean	gel	 (Bio-RAD).	
For	each	lane,	based	on	quantification	of	the	protein	from	the	BCA	assay,	25	µg	of	protein	
were	loaded	along	with	1X	final	loading	dye	(750	mM	aminocaproic	acid,	50	mM	Bis-Tris,	
0.5	mM	EDTA,	5%	Coomassie	blue,	pH	7.0).	A	high	molecular	weight	ladder	was	loaded	
(GE	17044501).	The	inner	chamber	was	filled	with	cathode	buffer	A	(15	mM	Bis-Tris,	50	
mM	Tricine,	Coomassie	blue	0.02%,	pH	7.0)	and	the	outer	chamber	was	filled	with	clear	
anode	buffer	(50	mM	Bis-tris,	pH	7.0).31	The	gel	was	run	at	30	V	for	30	minutes,	and	then	
increased	to	80	V.	As	the	sample	ran	farther	into	the	gradient,	the	current	dropped	below	
zero,	and	the	voltage	was	raised	to	100	V	and	then	110	V.	After	two	hours	(or	when	the	
blue	dye	front	migrated	halfway	through	the	gel),	the	blue	cathode	buffer	A	was	changed	
to	clear	cathode	buffer	B	and	run	for	two	additional	hours,	until	the	blue	dye	had	run	out	
of	the	gel.	The	gel	was	disassembled	and	allowed	to	soak	in	transfer	buffer	(	25	mM	Tris,	
192	mM	glycine,	0.05%	SDS)	for	10-15	minutes	prior	to	transfer.	
The	gel	was	then	transferred	to	a	PVDF	membrane.	Before	the	transfer,	the	PVDF	
membrane	 was	 activated	 in	 methanol	 for	 one	 minute.	 Following	 activation,	 the	
membrane	 was	 washed	 twice	 in	 water	 and	 equilibrated	 in	 ice	 cold	 transfer	 buffer.	
Proteins	were	transferred	overnight	at	30	V	in	the	refrigerator.	Prior	to	western	blotting,	
the	membrane	was	washed	in	water	and	re-equilibrated	in	methanol.	The	membrane	was	
dried	and	blotted.	
Western	Blot	
To	 blot	 for	 proteins	within	 the	 different	 complexes,	 the	 dried	membrane	was	
rehydrated	 in	1X	PBS	(phosphate	buffered	saline,	Sigma	Aldrich).	The	membrane	was	
	 18	
incubated	overnight	in	the	refrigerator	with	the	respective	antibody	prepared	in	blocking	
buffer	(PBS	containing	1%	casein,	0.04%	Tween-20).	The	following	day,	the	membrane	
was	 washed	 in	 1X	 PBS	 for	 5	 minutes	 three	 times.	 The	 blot	 was	 incubated	 with	 the	
appropriate	secondary	antibody	(donkey	anti-mouse	for	all),	at	room	temperature	 for	
one	hour.	Following	incubation,	the	membrane	was	washed	three	times	for	5	minutes	in	
1X	 PBS.	 The	 membrane	 was	 developed	 by	 adding	 the	 ECL	 substrate	 horseradish	
peroxidase	(HRP,	Luminata	crescendo,	Millipore	Sigma),	and	the	image	was	captured	in	
the	ChemiDoc-It	Imager.	A	white	light	image	was	captured	to	visualize	the	ladder.	
Image	J	Software	
Changes	in	amount	of	protein	between	wild-type	and	SOD2	were	quantified	using	
Image	J.	Band	intensities	were	normalized	to	quantification	of	the	entire	lane	using	the	
white	light	image	of	the	Coomassie	blue	stained	lane.	Normalization	was	performed	by	
dividing	the	pixels	obtained	for	each	complex	by	the	pixels	obtained	from	the	entire	lane.	
Each	wild-type	band	was	divided	by	the	average	of	all	wild-type	bands	to	normalize	wild-
type	to	1.0.	SOD2	intensity	was	also	normalized	to	the	intensity	of	the	wild-type	samples.		
OXPHOS	Activity	Assays	
Mitochondrial	Isolation	
To	isolate	mitochondria,	differential	centrifugation	was	performed	as	described.32	
To	summarize,	mouse	 liver	 tissue	(50	mg)	was	homogenized	 in	a	Teflon-glass	Potter-
Elvehjem	homogenizer	and	solubilized	in	0.5	mL	IBc	buffer	[10	mM	Tris-MOPS	(from	0.1	
M	Tris	buffered	 to	pH	7.4	with	MOPS	powder),	 10	mM	EDTA-Tris	 (from	0.1	M	EDTA	
buffered	to	pH	7.4	with	Tris	powder),	0.2	M	sucrose	buffer,	pH	7.4].	The	homogenate	was	
then	transferred	to	an	Eppendorf	tube	and	centrifuged	at	600	x	g	for	10	min	at	4	°C.	The	
	 19	
supernatant	was	transferred	to	a	new	Eppendorf	tube	and	centrifuged	at	7,000	x	g	for	10	
min	at	4	°C.	The	pellet	from	this	spin	was	washed	in	IBc	buffer,	and	re-pelleted	at	7,000	x	
g	for	10	min	at	4	°C.	The	pellet	was	then	resuspended	in	a	small	amount	(100	µL)	of	IBc	
buffer	and	put	on	ice	to	be	used	fresh.	The	amount	of	protein	was	measured	using	the	
BCA	assay	kit.	
NADH	Dehydrogenase	(Complex	I)	Assay	
In	 order	 to	 determine	 the	 activity	 of	 complex	 I	 in	 the	 isolated	 mitochondria,	
methods	were	used	as	described.33	This	assay	is	spectrophotometric	and	the	change	in	
absorbance	was	measured	at	600	nm	for	5	minutes,	as	DCIP	reduction	is	coupled	with	
NADH	oxidation	(Figure	7).	To	each	well,	15	µg	of	mitochondria	(5	µL)	were	added	as	
well	as	195	µL	of	master	mix.	The	master	mix	contained	2	mM	KCN	(to	inhibit	complex	
IV),	4	µM	Antimycin	A	(to	inhibit	complex	III),	100	µM	decylubiquinone	as	the	terminal	
electron	acceptor,	3.5	mg/mL	BSA,	60	µM	DCIP,	150	µM	NADH	as	the	electron	donor,	and	
80	mM	Tris	pH	7.4	–	0.5%	Tween-80.	To	determine	specificity	of	this	assay	for	complex	
I,	 rotenone	was	used	as	an	 inhibitor.	Rotenone	 inhibits	 the	 transfer	of	electrons	 from	
complex	 I	 to	ubiquinone.	Activity	 in	 the	absence	of	rotenone	was	subtracted	 from	the	
activity	in	the	presence	of	rotenone	to	show	activity	due	to	complex	I	only.	The	equation	
used	to	calculate	the	specific	activity	for	each	of	the	assays	was:	
Units×mg)* =
,-..
/01 ×*,33345/75		×9::9;	<=>?7@	(B)	
DEFGH×:97I>@	<=>?7@	 7B ×J=KJ@KLM9LN=K	 /O/P
			 			 									(equation	2)	
Succinate	Dehydrogenase	(Complex	II)	Assay	
In	order	to	determine	the	activity	of	complex	II	in	the	mitochondria,	methods	from	
“Biochemical	Assays	for	Mitochondrial	Activity:	Assays	of	TCA	Cycle	Enzymes	and	PDHc”	
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were	used.34	To	summarize,	15	µg	of	mitochondria	were	incubated	in	500	µL	of	0.1	M	
Tris-HCl	 pH	 7.4	 and	 100	 µL	 of	 0.2	 M	 sodium	 succinate	 for	 20	 minutes	 at	 room	
temperature.	Following	preincubation,	10	µL	of	0.2	M	KCN,	10	µL	of	5	mM	DCIP,	and	25	
µL	of	65	mM	phenazine	methosulfate	were	added.	The	reduction	of	DCIP	and	PMS	was	
coupled	 with	 the	 oxidation	 of	 succinate	 to	 fumarate.	 The	 change	 in	 absorbance	 was	
measured	at	600	nm.	No	inhibitor	was	used.	Two	SOD2	and	two	wild-type	samples	were	
used	for	this	assay.	Equation	2	was	used	to	calculate	the	specific	activity	for	each	assay.	
Aconitase	Activity	Assay	
To	perform	an	aconitase	activity	assay,	an	aconitase	activity	assay	kit	was	used	
(#705502	Cayman	Chemical).	To	summarize,	50	µg	(50	µL)	mitochondria	was	added	to	
each	well,	along	with	5	µL	assay	buffer,	50	µL	NADP+,	and	50	µL	isocitric	dehydrogenase	
provided	 in	 the	 kit.	 Concentrations	 and	 components	 of	 buffers	 are	 proprietary.	 The	
reaction	was	initiated	with	50	µL	substrate	solution	provided.	Absorbance	was	measured	
every	minute	 for	30	minutes	at	340	nm.	Each	sample	background	was	measured	and	
subtracted	 from	 the	activity	 from	 the	wild-type	and	SOD2	samples.	Aconitase	activity	
(nmol/min/mL)	was	determined	with	the	following	equation:	
QRS.(:97I>@))QRS.(T9JUVM=?KW)
3.33Y*Y	45Z[
× L=L9>	<=>?7@
IM=L@NK	<=>?7@
×sample	dilution		 	 (equation	3)	
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Results	and	Discussion	
Blue	Native-PAGE	
Complex	I	
	 Western	 blotting	 of	
NDUFS3	 separated	 by	 BN-PAGE	
indicated	no	change	in	complex	I,	
a	 subunit	 of	 complex	 I	 (Figure	
14A).	 Quantitation	 of	 complex	 I	
band	 intensity	normalized	 to	 the	
Coomassie	blue	stained	total	lane	
also	 indicated	 no	 change	 in	
complex	I	between	wild-type	and	
SOD2	 samples	 (Figure	 14B).	 A	
student’s	 unpaired	 t-test	 was	
performed	 and	 showed	 no	
significant	difference.	
Complex	II	
Western	blotting	of	complex	II	separated	by	BN-PAGE	indicated	a	decrease	in	the	
SOD2	mice	in	SDHA,	a	subunit	of	complex	II	(Figure	15A).	Quantitation	of	complex	II	band	
intensity	normalized	to	the	Coomassie	blue	stained	total	lane	indicated	a	~60%	decrease	
in	complex	II	in	the	SOD2	samples	compared	to	the	wild-type	samples	(Figure	15B).	The	
complex	II	(wild-type	and	SOD2)	bands	were	normalized	to	the	Coomassie	blue	staining	
A 	
B	 				 	
Figure	14.	(A)	Blue-native	PAGE	western	blots	
for	 NDUFS3	 (complex	 I).	 (B)	 Fold	 change	
indicating	no	difference	in	amount	of	complex	I.	
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and	wild-type	bands	and	quantified	(Figure	15B).	This	agrees	with	previous	preliminary	
data	obtained	by	Yichong	Zhang	based	on	the	protein	levels	if	SDHB	(Figure	13).	Repeat	
of	 this	 experiment	 in	 a	 second	 cohort	 of	mice	 showed	 a	 similar	 trend	but	 Coomassie	
staining	was	too	dark	and	unable	to	be	quantitated	(Figure	16B).A	student’s	t-test	was	
performed	and	determined	that	p<0.05,	so	the	values	were	statistically	different	between	
the	SOD2	and	wild-type	samples	for	both	experiments.	
A	 			B		 	
Figure	 15.	 (A)	 Blue-native	 PAGE	 western	 blot	 for	 (SDHA	 (complex	 II).	 (B)	
Quantification	of	pixel	density	of	western	blot	shown	in	(A)	using	Image	J.	Pixel	density	
for	each	sample	was	normalized	the	loading	control	and	then	to	the	average	density	
for	wild-type	mice.	*indicates	p<0.05,	determined	by	student’s	unpaired	t-test.	
	
A	 				B	 	
Figure	16.	 (A)	Repeat	of	 blue-native	PAGE.	Coomassie	Blue	 staining	 from	 the	gel	
could	not	be	quantitated.	(B)	Quantification	of	pixel	density	of	western	blot	shown	in	
(A)	 using	 Image	 J.	 Pixel	 density	 for	 each	 sample	 was	 normalized	 to	 the	 average	
density	 for	wild-type	mice.	*indicates	p<0.05,	determined	by	student’s	unpaired	t-
test.	
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Complex	III	
	 Western	blotting	of	 complex	 III	 separated	by	BN	PAGE	 indicated	no	 change	 in	
UQCRC2,	a	subunit	of	complex	III	(Figure	17A).	Quantitation	of	complex	III	band	intensity	
normalized	to	the	Coomassie	blue	stained	total	lane	confirmed	no	change	in	complex	III	
between	 wild-type	 and	 SOD2	 samples	 (Figure	17B).	 A	 student’s	 unpaired	 t-test	 was	
performed	to	determine	that	p>0.05,	and	SOD2	samples	were	not	statistically	different	
from	wild-type	samples.	This	agrees	with	the	preliminary	data	in	experiments	performed	
by	Yichong	Zhang	showing	no	difference	in	UQCRC2	for	complex	III	(Figure	13).	
	
	
	
	
	
	
	
	
A	 			B	 	
	
Figure	17.	(A)	Blue-native	PAGE	western	blots	for	Complex	III.	(B)	Fold	change	for	
complex	II	determined	by	quantitating	pixel	density	using	Image	J.	
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Complex	V		
Western	blotting	of	complex	V	separated	
by	BN	PAGE	 indicated	 a	 decrease	 in	ATP5A,	 a	
subunit	of	complex	V	(Figure	18A).	Quantitation	
of	complex	V	band	 intensity	normalized	to	 the	
Coomassie	 blue	 stained	 total	 protein	 lane	
indicated	a	~60%	decrease	 in	ATP5A	 levels	 in	
the	 SOD2	 samples	 compared	 to	 the	 wild-type	
samples	 (Figure	18B).	 The	 BN-PAGE	 was	
repeated	in	a	different	cohort	of	mice,	the	first	
being	from	liver	samples	brought	from	Yale,	and	
the	 repeat	 from	 tissue	harvested	 from	mice	at	
Appalachian	State	University.	The	results	 from	
the	second	cohort	of	mice	agree	that	there	is	a	
decrease	 in	 complex	 V	 in	 the	 SOD2	 samples	
compared	to	the	wild-type	samples	(Figure	19).	
A		 	B	 	
Figure	19.	 (A)	 Repeated	 Blue-native	 PAGE	western	 blots	 for	 Complex	 V.	 (B)	 Fold	
change	 for	 complex	 II	 determined	 by	 quantitating	 pixel	 density	 using	 Image	 J.	 *	
indicates	p<0.05,	determined	by	student’s	unpaired	t-test.	
	
A		 			
B		 	
Figure	 18.	 (A)	 Blue-native	 PAGE	
western	 blots	 for	 Complex	 V.	 (B)	
Fold	 change	 for	 complex	 V	
determined	 by	 quantitating	 pixel	
density	 using	 Image	 J.	 *	 indicates	
p<0.05,	 determined	 by	 student’s	
unpaired	t-test.	
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Activity	Assays	
NADH	Dehydrogenase	Activity	Assay	
An	 NADH	 dehydrogenase	 (complex	 I)	 activity	 assay	 was	 run	 by	 incubating	
mitochondria	with	 NADH	 as	 the	 electron	 donor	 and	 decylubiquinone	 as	 the	 electron	
acceptor.	The	DCIP-coupled	NADH	dehydrogenase	is	characterized	by	a	reduction	in	the	
absorbance	at	600	nm.	DCIP	in	its	reduced	form	has	no	absorbance	at	this	wavelength,	
therefore	 as	 the	 assay	 proceeds,	 there	 is	 a	 colorimetric	 change	 from	 blue	 to	 clear.	
Rotenone,	which	inhibits	complex	I,	was	used	to	determine	complex	I	specificity	of	the	
color	 change.	Although	 the	presence	of	 rotenone	 should	 show	a	70-80%	reduction	 in	
slope,	no	change	was	observed.	Assays	with	serial	dilutions	of	rotenone	were	run	to	try	
and	find	the	optimal	concentration	of	rotenone	necessary	to	 inhibit	complex	I	(Figure	
20).	Concentrations	of	0.125	µM	to	4	µM	rotenone	were	used	in	the	activity	assay,	but	
none	of	these	inhibited	complex	I.		
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A	 	B	 	
C	 	D	 	
E	 		F	 	
Figure	20.	Complex	I	activity	assays.	(A)	shows	no	rotenone	and	(B-F)	show	serial	
dilutions	of	rotenone	from	0.125	µM	rotenone	to	4	µM	rotenone.	Rotenone	did	not	
inhibit	NADH	oxidation	at	any	concentration.	
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To	troubleshoot	further,	each	component	of	the	assay	was	sequentially	removed	
in	a	series	of	control	reactions.	Conditions	tested	were:	no	mitochondria,	no	NADH,	no	
cyanide,	no	antimycin	A,	no	BSA,	and	no	decylubiquinone	(Figure	21).	In	the	absence	of	
mitochondria,	no	activity	was	observed	(Figure	21A,	B,	F).	Similarly,	 in	the	absence	of	
NADH,	no	activity	was	observed	(Figure	21B).	None	of	the	trials	adding	rotenone	resulted	
in	 a	 change	 in	 slope	 (Figure	 21A,	 C,	 D,	 E).	 Importantly,	 the	 assay	 in	 the	 absence	 of	
decylubiquinone	 still	 showed	 activity,	 indicating	 that	 the	 assay	 is	 decylubiquinone	
independent.	 There	was	 a	 15%	 difference	when	 the	mitochondria	were	 treated	with	
rotenone	for	 five	minutes	before	starting	the	reaction	with	the	master	mix	and	NADH	
(Figure	22).	The	average	rotenone-sensitive	specific	activity	at	600	nm	for	the	wild-type	
samples	was	0.00604	U/mg,	and	the	average	rotenone-sensitive	specific	activity	at	600	
nm	for	SOD2	samples	was	0.0121	U/mg	(Figure	22E).		
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A	 	B	 		
C	 	D	 	
E	 		F	 	
	
Figure	21.	Complex	I	activity	assays.	(A)	compares	activity	with	or	without	rotenone,	
and	shows	a	control	with	no	mitochondria.	(B)	shows	controls	with	either	no	NADH	
or	with	no	NADH	nor	mitochondria.	(C)	shows	controls	with	no	cyanide,	both	with	or	
without	 rotenone.	 (D)	 shows	 controls	 with	 no	 antimycin	 A,	 both	 with	 or	 without	
rotenone.	(E)	shows	controls	with	no	BSA,	both	with	or	without	rotenone.	(F)	shows	
controls	with	no	decylubiquinone	or	with	no	decylubiquinone	nor	mitochondria.	
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A	 	B	 		
C	 	D	 	
E	 	
Figure	22.	Complex	I	activity	assays	(A	and	B)	Change	in	absorbance	of	DCIP	
measured	at	600	nm	coupled	with	NADH	oxidation	for	wild-type	samples.	(C	and	D)	
Change	in	absorbance	of	DCIP	measured	at	600	nm	coupled	with	NADH	oxidation	for	
SOD2	samples.	(E)	Average	rotenone-sensitive	specific	activity	for	both	wild-type	
and	SOD2	samples.	There	are	no	error	bars,	as	data	was	collected	from	only	two	
samples.	
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Succinate	Dehydrogenase	Activity	Assay		
Activity	 of	 succinate	
dehydrogenase	 was	 tested	 by	
incubating	 mitochondria	 from	 wild-
type	 samples	 and	 SOD2	 samples	 with	
succinate	 as	 the	 electron	 donor	 and	
decylubiquinone	 as	 the	 electron	
acceptor.	 The	 assay	 shows	 a	 slight	
reduction	in	the	activity	of	complex	II	in	
the	 SOD2	 samples	 compared	 to	 the	
wild-type	 samples	 (Figure	 23).	 This	
change	 in	 activity	 does	 not	 represent	
the	 60%	 decrease	 in	 the	 amount	 of	
complex	II	observed	in	the	Western	blot	
for	SOD2	samples.	Figures	23A	and	23B	
were	not	normalized	to	 the	amount	of	
mitochondria	 in	 each	 sample.	 Figure	
23C	 shows	 the	 activity	 (U/mg)	
normalized	 to	 the	 amount	 of	
mitochondria	 in	 each	 sample	
determined	using	equation	2.		
	
	
A	 	
B	 	
C	 	
Figure	 23.	 Complex	 II	 activity	 assays.	 (A)	
Decrease	in	absorbance	due	to	the	activity	of	
complex	 II	 in	 wild-type	 samples.	 (B)	
Decrease	in	absorbance	due	to	the	activity	of	
complex	II	in	SOD2	samples.	(C)	Fold	change	
normalized	to	amount	of	protein	input	into	
the	 assay.	 In	 Figures	 A	 and	 B,	 the	 same	
volume	was	loaded	into	each	sample,	but	not	
the	same	amount	of	mitochondria.	Once	the	
protein	 amount	 was	 determined	 for	 each	
sample,	the	activity	was	normalized	in	figure	
C.	There	are	no	error	bars,	as	the	data	is	from	
two	samples.	
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Aconitase	Activity	Assay		
Because	 complex	 II	 functions	 in	 both	
the	 citric	 acid	 cycle	 and	 OXPHOS,	 aconitase	
activity	was	measured	to	show	whether	there	
was	citric	acid	cycle	dysfunction.	An	aconitase	
activity	 assay	 kit	 was	 used	 to	 determine	 the	
amount	of	aconitase	activity	 in	 the	citric	acid	
cycle.	The	aconitase	assay	shows	an	increase	in	
activity	for	the	SOD2	samples	compared	to	the	
wild-type	 samples	 (Figure	 24).	 This	 agrees	
with	a	previous	study	showing	a	slight	increase	
in	aconitase	activity	in	skeletal	muscle	in	young	
mice.20		
Discussion	
Complex	I	Abundance	and	Activity		
	 Preliminary	studies	were	unable	to	ascertain	differences	in	abundance	of	complex	
I	by	SDS-PAGE.	The	antibodies	available	for	Complex	I	are	extraordinarily	sensitive	to	
heat.	Therefore,	it	was	determined	that	BN-PAGE	was	a	better	experiment	to	determine	
complex	I	abundance.	No	change	was	observed	in	the	amount	of	intact	complex	I	by	BN-
PAGE	between	wild-type	and	SOD2	mice.	Preliminary	activity	assays	in	the	current	study	
indicated	SOD2	mice	had	slightly	 increased	activity	of	complex	 I.	However,	a	problem	
with	the	interpretation	of	the	activity	assay	is	that	the	rotenone-sensitive	activity	was	
less	 than	has	been	reported	(70-80%).35	The	 initial	conclusion	of	 increased	activity	 is	
					
	
Figure	24.	Aconitase	activity	in	two	
wild-type	and	three	SOD2	samples.	
Error	bars	are	missing	on	the	wild-
type	 samples	 because	 only	 two	
samples	were	able	 to	be	quantified	
from	the	A600.		
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based	on	a	15%	rotenone-sensitive	activity.	Despite	testing	serial	dilutions	of	rotenone,	
no	concentration	was	able	to	effectively	inhibit	complex	I.	Rotenone	sensitivity	has	been	
reported	to	be	less	in	the	liver	than	in	other	tissues7,	presumably	due	to	the	high	level	of	
NADH-dependent	 enzymes	 in	 liver	 mitochondria	 (malate	 dehydrogenase,	 pyruvate	
dehydrogenase,	alpha-ketogluterate	dehydrogenase,	etc.).	These	additional	enzymes	are	
rotenone	insensitive	and	would	therefore	increase	observed	background	activity.		
A	number	of	control	reactions	were	run	that	tested	each	component	of	the	assay.	
The	 first	 few	 trials	 tested	 activity	 in	 the	 presence	 and	 absence	 of	 rotenone,	 but	 no	
rotenone-sensitivity	 was	 observed	 (Figure	 22A).	 As	 expected,	 mitochondria	 were	
required	to	convert	NADH	to	NAD+.	Since	NADH	is	the	substrate	of	the	reaction,	it	was	
also	not	surprising	that	the	reaction	failed	to	proceed	in	the	absence	of	NADH	(Figure	
22B).	 It	 was	 problematic	 that	 the	 reaction	 proceeded	 in	 the	 absence	 of	 cyanide	 or	
antimycin	A.	Cyanide	 is	an	 inhibitor	of	 complex	 IV,	and	antimycin	A	 is	an	 inhibitor	of	
complex	 III.	 It	 is	 important	 to	 inhibit	 these	 complexes,	 as	 they	 are	 downstream	 of	
complexes	 I	 and	 II	 and	 any	 deficiency	 in	 downstream	 complexes	 could	 be	 falsely	
interpreted	as	a	deficiency	in	complex	I.	Complexes	III	and	IV	would	also	accept	electrons	
in	place	of	the	terminal	electron	acceptor,	and	thus	would	interfere	in	the	assay	readout.	
BSA	is	used	in	the	assay	to	increase	the	solubility	of	decylubiquinone	and	rotenone36,	but	
had	no	effect	when	removed	from	the	assay	(Figure	22E).	The	most	striking	observation	
in	the	control	reactions	was	that	the	absorbance	in	the	assay	proceeded	to	decrease	at	
600	nm	in	the	absence	of	decylubiquinone,	the	terminal	electron	acceptor	(Figure	22F).	
The	 activity	 assay	 depends	 on	 the	 transfer	 of	 electrons	 from	 complex	 I	 to	
decylubiquinone,	 and	 then	 from	 decylubiquinone	 to	 DCIP.	 In	 the	 absence	 of	
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decylubiquinone,	it	is	not	clear	how	electrons	would	be	transferred	to	DCIP	directly.	It	is	
possible	that	DCIP	is	accepting	electrons	directly	from	NADH,	which	would	indicate	that	
the	observed	activity	is	not	due	to	complex	I,	as	complex	DCIP	does	not	react	efficiently	
with	complex	I.37	There	may	also	be	a	sufficient	pool	of	ubiquinone	in	the	mitochondria	
samples	such	that	additional	decylubiquinone	is	not	necessary.	To	eliminate	secondary	
electron	transfer	effects	an	alternative	for	this	activity	assay	would	be	to	measure	the	
absorbance	 at	 340	 nm,	 since	 NADH	 absorbs	 at	 that	 wavelength	 and	 NAD+	 does	 not.	
However,	mitochondria	tend	to	have	a	high	background	absorbance	at	340	nm,	which	
interferes	in	this	assay.	
Complex	II	Abundance	and	Activity		
	 The	preliminary	microarray	showed	that	three	of	the	four	proteins	that	make	up	
complex	II	are	downregulated,	with	the	fourth	being	unchanged.	BN-PAGE	for	complex	II	
shows	a	decrease	in	the	amount	of	total	complex	assembly	in	the	SOD2	mice	compared	
to	the	wild-type	mice	(Figures	15	and	16).	This	reduction	agrees	with	preliminary	data	
that	showed	a	decrease	in	complex	II	by	both	BN-PAGE	and	SDS-PAGE	(Figure	13).	The	
complex	 II	 activity	 assay	 showed	 that	 SOD2	mice	 display	 slightly	 reduced	 activity	 of	
succinate	 dehydrogenase;	 however,	 more	 samples	 need	 to	 be	 analyzed	 to	 confirm	
significance	 since	 standard	 deviation	 cannot	 be	 determined.	 Additionally,	 given	 the	
issues	 with	 inhibitor-sensitivity	 of	 complex	 I,	 this	 assay	 should	 be	 repeated	 in	 the	
presence	of	malonate,	an	inhibitor	of	complex	II.	Since	no	other	mitochondrial	enzymes	
use	succinate	as	a	substrate,	malonate	inhibition	is	typically	not	performed.		
	 When	the	activity	from	complexes	I	and	II	are	analyzed,	it	appears	that	SOD2	mice	
have	increased	complex	I	activity	and	decreased	complex	II	activity.	Since	both	of	these	
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complexes	 contribute	 to	 the	 decylubiquinol	 pool,	 they	 are	 in	 a	 way	 functionally	
redundant.	It	is	possible	that	because	complex	II	is	reduced	in	abundance	and	activity,	
complex	I	is	increasing	activity	as	a	compensatory	mechanism.		
Complex	III	Abundance	
	 Preliminary	studies	indicated	no	change	in	complex	III,	and	a	confirmation	BN-
PAGE	using	additional	wild-type	ad	SOD2	mice	confirmed	this	 finding.	Since	BN-PAGE	
and	 SDS-PAGE	 indicated	 no	 change	 in	 complex	 abundance,	 no	 activity	 assays	 were	
performed	for	this	complex.		
Complex	V	Abundance	
	 Preliminary	SDS-PAGE	indicated	no	change	in	complex	V.	However,	BN-PAGE	in	
current	studies	shows	a	decrease	in	assembly	of	this	complex	in	SOD2	samples.	Current	
studies	have	repeated	this	experiment	using	two	cohorts	of	mice,	which	both	indicated	
reduced	complex	V	assembly	 in	SOD2	mice	(Figures	18	and	19).	 It	 is	critical	 that	ATP	
production	in	these	samples	be	measured	in	order	to	confirm	a	functional	consequence	
of	reduced	complex	assembly.		
Complex	II	and	the	Citric	Acid	Cycle	
	 One	of	the	most	striking	observations	in	this	study	is	the	reduction	in	complex	II	
since	complex	II	functions	in	the	citric	acid	cycle	as	well	as	OXPHOS.	Analysis	of	citric	acid	
cycle	activity	by	the	aconitase	activity	assay	showed	an	increase	in	the	SOD2	samples.	
This	agrees	with	previous	studies	that	also	showed	an	increase	in	aconitase	activity	in	
SOD2	mice	 in	 muscle.20	 It	 is	 unusual	 to	 have	 high	 levels	 of	 aconitase	 upstream	 of	 a	
dysfunctional	succinate	dehydrogenase,	since	a	buildup	of	succinate	could	cause	product	
inhibition	of	aconitase.	However,	since	the	citric	acid	cycle	is	the	metabolic	hub	of	the	
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cell,	intermediates	of	the	cycle	could	be	leaving	to	affect	other	pathways.	For	example,	
succinyl-CoA	can	leave	the	citric	acid	cycle	and	combine	with	glycine	in	the	first	step	of	
porphyrin	synthesis.38		
Aconitase	is	ROS	sensitive	because	ROS	have	the	ability	to	damage	its	iron	sulfur	
centers.30	 Superoxide	 oxidizes	 the	 iron	 and	 is	 reduced	 to	 hydrogen	 peroxide.	 In	 the	
presence	of	increased	SOD2,	reduced	oxidative	damage	to	aconitase	is	thought	to	cause	
its	increased	activity.	The	aconitase	assay	indicates	no	defect	in	the	early	phases	of	citric	
acid	cycle	upstream	of	succinate	dehydrogenase.		This	assay	also	looks	at	overall	citric	
acid	cycle	health.	However,	downstream	enzymes	(fumarase	and	malate	dehydrogenase)	
and	pathways	such	as	porphyrin	synthesis	still	need	to	be	tested.		
Conclusion/Future	Plans	
Currently	there	is	not	an	assay	to	use	that	looks	at	the	amount	of	ROS	in	tissue,	
which	 would	 be	 beneficial	 to	 determine	 the	 amount	 of	 superoxide	 and	 hydrogen	
peroxide	found	in	the	mitochondria.	Knowing	this	would	show	whether	SOD2	mice	have	
increased	levels	of	hydrogen	peroxide	compared	to	wild-type	mice.	If	SOD2	mice	have	
more	hydrogen	peroxide	than	wild-type	mice,	this	ROS	could	be	affecting	the	OXPHOS	
complexes.		
Because	aconitase	is	increased	and	succinate	dehydrogenase	is	decreased	in	SOD2	
mice,	 a	 complete	 metabolic	 analysis	 of	 the	 citric	 acid	 cycle	 pathways	 is	 needed	 to	
determine	 which	 are	 upregulated	 and	 which	 are	 downregulated.	 This	 would	 help	
determine	which	 intermediates	are	 leaving	to	perform	other	 functions,	and	which	are	
inhibited	due	to	the	inhibition	of	succinate	dehydrogenase.			
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